Cancer Research

Three Studies Presented At 43rd EASL Strongly Indicate Better Efficacy For PEGASYS In Curing Hepatitis C

BASEL, Switzerland, April 26 /PRNewswire/--- Roche Also Provides Comment on Results of "IDEAL" Trial Roche today announced that compelling new data from three studies indicate that chronic hepatitis C patients who received PEGASYS(R) (peginterfe ...

Article - Anna Ohlden - Apr 26 2008 - 12:31pm

Molecular Discoveries Shed Light On Liver Cancer-- Hepatocellular Carcinoma (HCC)

MILAN, Italy, April 27 /PRNewswire/--- Genomics improves our ability to target experimental cancer treatments- A promising new drug is in hand, and more are on the way- Improved ability to select patients to test particular drugs At today's sessions ...

Article - Anna Ohlden - Apr 26 2008 - 11:31pm

CYP1A2 Gene Variant May Cause Coffee To Prevent Breast Cancer

Depending on which variant of the gene CYP1A2 a woman has, a coffee consumption rate of at least two cups a day can either reduce the total risk of developing breast cancer or delay the onset of cancer, according to new research from Lund University and Ma ...

Article - News Staff - Apr 27 2008 - 11:53am

Story Of Woman's Courage And Medical Innovation Top Choice For Readers

TORONTO, April 28 /PRNewswire/-- Readers in Europe and other parts of the world are enjoying Lifeliner: The Judy Taylor Story, the debut book from London-born author Shireen Jeejeebhoy. It tells the moving and poignant story of a Canadian woman who made m ...

Article - Anna Ohlden - Apr 28 2008 - 2:31am

Zsweet(R): Improving Life For Diabetics And The Overweight

DUBLIN, April 28 /PRNewswire/-- The modern world is entrenched in a love-hate affair with sugar. It proliferates throughout our daily diet, we crave it, we adore it and yet it destroys our health. To view the Multimedia News Release, please click: http:// ...

Article - Anna Ohlden - Apr 28 2008 - 2:31am

Story Of Woman's Courage And Medical Innovation Top Choice For Readers

TORONTO, April 28 /PRNewswire/-- Readers in Europe and other parts of the world are enjoying Lifeliner: The Judy Taylor Story, the debut book from London-born author Shireen Jeejeebhoy. It tells the moving and poignant story of a Canadian woman who made m ...

Article - Anna Ohlden - Apr 28 2008 - 2:31am

Unite Accuses Semiconductor Companies Of Living In An Alice In Wonderland Fantasy Over Workers' Safety

LONDON, April 28 /PRNewswire/-- Unite the union has today on Workers' Memorial Day called the approach by the semiconductor industry, in response to the Health and Safety Minister's support for the view that the industry should fund a national s ...

Article - Anna Ohlden - Apr 28 2008 - 4:31am

Researchers Find Adult Stem Cells In Adapting Pituitary Gland

Maturity, in some respects, brings diminished possibilities. As a fertilized egg cell repeatedly divides to grow into a mature animal, most of the resulting cells become ever more specialized. But a small number of cells, known as stem cells, remain uncomm ...

Article - News Staff - Apr 28 2008 - 5:16pm

Does Fusion Theory Not Get Enough Respect In Cancer Research?

Metastasis, the spread of cancer throughout the body, can be explained by the fusion of a cancer cell with a white blood cell in the original tumor, according to Yale School of Medicine researchers, who say that this single event can set the stage for canc ...

Article - News Staff - Apr 30 2008 - 12:35am

Merck Serono Announces Initiation Of Phase II Clinical Trial Of Atacicept In Relapsing Multiple Sclerosis

GENEVA, Switzerland, April 30 /PRNewswire/-- Merck Serono (NYSE: SRA), a division of Merck KGaA, Darmstadt, Germany, and its partner ZymoGenetics, Inc. (NASDAQ: ZGEN) today announced the initiation of a Phase II clinical trial to evaluate the safety and e ...

Article - Anna Ohlden - Apr 30 2008 - 5:32am